Skip to main content
NTHI logo

NTHI

Neonc Technologies Holdings, Inc.
$4.47 +0.05 (+1.13%) At close · Jul 6
Market Cap
$116.28M
Shares
26,013,136

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.47 Open$4.46 Day$4.33–4.47 52W$3.69–12.99 Avg vol 30d94K Short int271K · 1.0% float · 2.8d Short vol87% Last earningsMay 18, 2026 DataMar 2025–Jul 2026 Filing10-Q · May 15
Equibles Rating blended score · not investment advice
Overall
Sell
Technical · trend & momentum Strong Sell
50 / 200-day cross no cross
Price vs 200-day avg −44% below
Price vs 50-day avg −8% below
RSI (14) 44 · neutral
MACD trend negative
52-week position 8% · near low
Sentiment · smart money Bullish
Trend (MA cross) 50d $5 › 200d $8 — 200d above 50d
+ Institutional flow +170% holders QoQ · +18 funds added
+ Insider flow Net +$270.2K over 90 days · 0% sells
Short interest 1.04% of float · ▲ +0.7% MoM · 2.8 days cover
Volume signal Volume near normal
+ Institution breadth 27 holders — near 1-yr high, broad support
Fundamentals Weak
Revenue growth −52% Y/Y
EPS growth −364% Y/Y
+ Balance sheet net cash $58.7K

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Up next
Next earnings call
Sep 30, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 15, 2026

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
no cross Neutral
Price vs 200-day avg
−44% below Bearish
Price vs 50-day avg
−8% below Bearish
RSI (14)
44 · neutral Neutral
MACD trend
negative Bearish
52-week position
8% · near low Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $5 › 200d $8 — 200d above 50d
Institutional flow Accumulating
+170% holders QoQ · +18 funds added
Insider flow Accumulating
Net +$270.2K over 90 days · 0% sells
Short interest Rising
1.04% of float · ▲ +0.7% MoM · 2.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
27 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $4 Now $4 · 8% 52-wk high $13
vs 200-day avg -44% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings
Metric Latest Period YoY
Normalized cash operating expenses (annualized, approximate) non-GAAP $24.4M Q1 2026
Normalized cash operating expenses (approximate) non-GAAP $6.1M Q1 2026
Radiographic remission rate (NEO100) 24% Q1 2026
Recommended Phase 2 Dose (RP2D) for NEO212 610 Q1 2026
Six-month progression-free survival (NEO100) 44% Q1 2026

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NTHI
Neonc Technologies Holdings, Inc.
this stock
$116.28M -45.9% -51.8% 1.0%
AKTX
Akari Therapeutics Plc
$953.21B -9.9% 0.0%
ONC
BeOne Medicines Ltd.
$470.30B -2.0% +22179.2% 957.1 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
$134.41B +16.8% +46.2% 31.4 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
$69.80B -15.1% +20.8% 16.3 3.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
27
% held
11.1%
Net QoQ
+2.2M sh
Top holder
Cinctive Capital Manageme…
Held Float
View
Held by Funds
Fund positions
11
View
Short & Settlement
Short Interest Rising
Shares short
270.5K
Days to cover
2.8d
Change
+2.0K sh
View
Short Volume
Short vol %
87%
As of
Jul 6, 2026
Short Total
View
Fails to Deliver
FTD shares
917
Value
$4.1K
As of
Jun 10, 2026
View
Off-Exchange
Off-exchange %
54.4%
Week of
May 4, 2026
Off-exch Lit
View
Smart Money
Insider Trades Cluster buy
Net (90d)
+$270.2K
Buyers / Sellers
3 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$40.0K
Net income (FY)
$-62.1M
EPS diluted
$-3.20
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 2, 2026
This year
20
View
Exempt Offerings
Offering
$5.0M
Filed
Jun 25, 2026
View
Earnings & Events
Earnings Calls
Last call
May 18, 2026
View
Investor Relations
Latest news
NeOnc Technologies Receives UAE I…
Published
Jun 23, 2026
View

Performance

5D 20D 120D MTD YTD
NTHI -2.4% -2.1% -55.3% -1.3% -46.0%
SPY +1.4% -1.3% +8.0% -0.3% +9.2%
vs SPY -3.8% -0.8% -63.3% -1.1% -55.2%
Key facts CIK 1979414 CUSIP 64051A101 Visit website Investor relations